Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

NEXGEL, INC. (NXGL)

$0.44 +2.09% NASDAQ: NXGL · 15-min delayed
  • LANGHORNE, Pennsylvania
  • Public · NASDAQ: NXGL
  • 19 employees
$5.1MMarket cap
$11.4MRevenue · FY2025
-$3.0MNet income
19Employees
NXGLNASDAQ
2021IPO

About NEXGEL, INC.

NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$11.4M
Net income
-$3.0M
Total assets
$10.5M
Market cap
$5.1M
Gross margin
39.5%
Operating margin
-29.3%
Net margin
-25.3%

Source: SEC EDGAR · updated Jun 8, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$11.4M
Cost of revenue
$6.9M
Gross profit
$4.5M
Operating expenses
$7.9M
Operating income
-$3.4M
Net income
-$2.9M
EPS (basic)
$-0.38
EPS (diluted)
$-0.38

Balance sheet

Total assets
$10.5M
Current assets
$4.3M
Total liabilities
$5.6M
Current liabilities
$3.0M
Shareholders’ equity
$4.9M

Cash flow

Operating cash flow
-$1.3M
Investing cash flow
-$68.0K
Financing cash flow
$630.0K
Net cash flow
-$749.0K

Statements via Polygon.io (SEC filings)

NASDAQ: NXGL
$0.44 +2.09%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.41 $2.78

52-week range

Market cap
$5.1M
EPS (diluted)
$-0.38
Shares outstanding
11.6M
Open
Day range
Prev close
Volume
IPO date
Dec 22, 2021

Nexgel, Inc. (NXGL) Stock Price

  • Reported a net loss of $3.0M in FY2025.
  • Revenue grew 636% from FY2021 to FY2025.
  • Gross margin of 39.5%, net margin -25.3%.
  • Trading 84% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review NEXGEL, INC..

Write a review
Newsroom

News about NEXGEL, INC.

News & sentiment via Polygon.io

FAQ

Nexgel, Inc.: frequently asked questions

Is Nexgel, Inc. an American company?

Nexgel, Inc. is a US-based company headquartered in Langhorne, Pennsylvania, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Nexgel, Inc. headquartered?

Nexgel, Inc. is headquartered in Langhorne, Pennsylvania, United States.

Is Nexgel, Inc. publicly traded?

Yes — Nexgel, Inc. is a publicly traded company. Its stock trades under the ticker symbol NXGL on the NASDAQ.

What does Nexgel, Inc. do?

Nexgel, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →